Cargando…
The Impact of the US Priority Review Voucher on Private-Sector Investment in Global Health Research and Development
Autores principales: | Robertson, Andrew S., Stefanakis, Rianna, Joseph, Don, Moree, Melinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429395/ https://www.ncbi.nlm.nih.gov/pubmed/22953004 http://dx.doi.org/10.1371/journal.pntd.0001750 |
Ejemplares similares
-
Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade
por: Stefanakis, Rianna, et al.
Publicado: (2012) -
Leishmaniasis: Middle East and North Africa Research and Development Priorities
por: McDowell, Mary Ann, et al.
Publicado: (2011) -
Research Priorities for Neglected Infectious Diseases in Latin America and the Caribbean Region
por: Dujardin, Jean-Claude, et al.
Publicado: (2010) -
Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming
por: Williams, David J., et al.
Publicado: (2019) -
Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges
por: Tediosi, Fabrizio, et al.
Publicado: (2013)